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Abstract
The process of macroautophagy (referred to hereafter 
as autophagy), is generally characterized by the prom-
inent  formation  of  autophagic  vesicles  in  the 
cytoplasm. In the past decades, studies of autophagy 
have been vastly expanded. As an essential process to 
maintain cellular homeostasis and functions, autoph-
agy is responsible for the lysosome-mediated degra-
dation of damaged proteins and organelles, and thus 
misregulation of autophagy can result in a variety of 
pathological conditions in human beings. Although 
our understanding of regulatory pathways that control 
autophagy is still limited, an increasing number of 
studies have shed light on the importance of autoph-
agy in a wide range of physiological processes and hu-
man diseases. The goal of the reviews in the current is-
sue is to provide a general overview of current knowl-
edge on autophagy. The machinery and regulation of 
autophagy were outlined with special attention to its 
role  in  diabetes,  neurodegenerative  disorders,  in-
fectious diseases and cancer.
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What is autophagy? 
Macroautophagy (referred to hereafter as autophagy) 
is a genetically regulated and dynamic process 
associated with the formation of autophagosome, a 
double-membrane cytoplasmic vesicle that engulfs 
cellular components. The autophagosome formation 
starts at phagophore (also known as isolation mem-
brane or sequestering membrane) and requires the 
conjugation of microtubule-associated protein 1 
light chain 3 (LC3), which regulates the phagophore 
expansion and completion of the sequestering 
vesicle (Xie et al., 2008). The completed auto-
phagosome then fuse with lysosome, becoming 
autolysosome. Sequestered components are de-
graded by lysosomal hydrolases and released into 
the cytosol by lysosomal efflux permeases. This 
lysosome-mediated degradation system plays a 
regulatory role in mammalian cell biology by clearing 
damaged organelles and recycling autophagy-derived 
nutrients (Figure 1).
General functions of autophagy
The process of protein degradation and organelle 
turnover is required for the survival of cells, and the 
disruption of this process can result in the abnor-
mal cell growth or cell death, leading to various dis-
ease states (Klionsky and Emr, 2000). In eukary-
otic cells, this process is mainly regulated by two 
major systems named the ubiquitin-proteasome 
system (UPS) and autophagy, which work cooper-
atively to control intracellular protein degradation 
and organelle turnover (Klionsky and Emr, 2000; 
Rubinsztein, 2006). Whereas the UPS specializes 
in short-lived protein degradation, autophagy main-
ly functions to degrade long-lived proteins and 
damaged organelles (Rubinsztein, 2006; Nedelsky 
et al., 2008). Although autophagy is considered to 
be a nonselective degradation process of engulf-
ment of cytoplasm traditionally, increasing evidence 
indicates the existence of selective autophagy which 
specifically degrades mitochondria (mitophagy), endo-
plasmic reticulum (reticulophagy), microorganisms 
(xenophagy) and aggregated proteins (aggrephagy), 
etc. (Johansen and Lamark, 2011).
     Depending on the different cellular contexts and 
stimuli, the outcome of autophagy can promote either 70    Exp. Mol. Med. Vol. 44(2), 69-72, 2012
Figure 1. Schematic diagram of autophagic progression. Autophagy induction signal leads to form a sequestering membrane called phagophore. 
Following a sequence of ubiquitination-like reactions, LC3 conjugates to the sequestering membrane and controls the elongation of phagophore. As the 
phagophore expands, cytoplasmic constituents, including organelles such as mitochondria and endoplasmic reticulum, aggregated proteins and foreign 
organisms (bacteria and virus) are enwrapped. At the end of elongation, sequestering membrane closes and results in the formation of a double-mem-
brane vesicle, autophagosome. Once the autophagosome is formed, it is delivered to fuse with lysosome to form autolysosome for degradation. 
Lysosomal hydrolases degrades the cargo together with the inner membrane of autophagosome, and LC3 from the outer membraneas well as the autoph-
agy-derived nutrients are recycled.This autophagic process can act as a mechanism to keep homeostatic balance and support cell survival. However, it 
can also cause cell death directly or indirectly.
cell survival or cell death. However, the mechanisms 
underlying the dual role for autophagy in deciding 
the destiny of cells remain unclear. On one hand, 
since autophagy provides cells with nutrients and 
eliminates damaged organelles, it is primarily believed 
to function as a protective mechanism for cell 
survival, particularly under unfavorable conditions. 
Indeed, cytotoxic drugs often trigger autophagy 
activation, and then autophagy inhibition has been 
reported to potentiate apoptotic cell death induced 
by several anticancer drugs (Amaravadi et al., 
2007; Song et al., 2008). Nevertheless, autophagy 
impairment can also block or delay the develop-
ment of cell death (Berry and Baehrecke, 2007; 
Yuk et al., 2010; Jing et al., 2011), and in some 
instances, autophagy itself is capable of inducing 
cell death (Shao et al., 2004; Yousefi et al., 2006). 
This role of autophagy in enhancing cell death may 
be related to the degradation of essential factors for 
cell survival (Yu et al., 2006) or its effect on energy 
maintenance considering that ATP is required during 
programmed cell death, such as apoptosis (Qu et 
al., 2007).
The impacts of autophagy on human 
physiology and diseases
Nearly all eukaryotic cells undergo autophagy at a 
basal level under normal physiological conditions, and 
cells deficient in autophagy show diffuse abnormal 
protein accumulation and mitochondria disorganization 
(Hara et al., 2006; Ebato et al., 2008), suggesting that 
cells use autophagy to maintain cellular homeostasis 
by eliminating damaged organelles and protein ag-
gregates, which resist degradation via UPS in nor-
mal growing conditions. In addition to the effect on 
cellular homeostasis maintenance, autophagy also 
regulates rapid cellular changes essential for mam-
malian development and differentiation. For instance, 
it has been demonstrated that autophagy is required 
in mitochondrial elimination during erythrocyte and 
adipocyte maturation (Mortensen et al., 2010; 
Goldman et al., 2011). Furthermore, autophagy is 
not only responsible for the clearance of abnormal 
proteins and organelles, but also participates in the 
removing of infectious agents, including bacteria 
and viruses from host cells. Recent data from stud-Autophagy in human diseases    71
Figure 2. Dysregulated autophagy is
involved in several human diseases. 
Autophagy contributes to maintain 
cellular homeostasis and is critical 
in a wide range of normal human 
physiological processes. Accordingly,
a growing number of diseases are 
linked to the misregulation of auto-
phagic process.  × ◯, dysregulation of 
autophagy.
ies of cell models show that autophagy upregulation 
might be valuable for eliminating Mycobacterium 
tuberculosis (Gutierrez et al., 2004), Streptococcus 
(Nakagawa et al., 2004), mycobacteria (Singh et 
al., 2006; Shin et al., 2010) and herpes simplex vi-
rus (Talloczy et al., 2006). This function of autoph-
agy appears to be accounted for by both innate 
and adaptive immune responses (Levine and 
Deretic, 2007).
     Because  of  the  importance  of  autophagy  in 
mammalian physiology, it is therefore reasonable 
to assume that autophagy impairment could con-
tribute to human diseases. However, although au-
tophagy was first described morphologically in 
mammalian cells in 1960s (Deter et al., 1967), until 
the discovery of a group of autophagy-related (ATG) 
genes in 1990s (Tsukada and Ohsumi, 1993), the 
role of autophagy in various human disease states 
was unclear, and only in the past decade has the 
connection between autophagy and human dis-
ease become the subject of intense study. To date, 
autophagy has been linked to a growing list of dis-
eases, and it appears that more autophagy-asso-
ciated diseases will be discovered in the future. 
Although the exact mechanisms underlying the au-
tophagy-associated diseases at the molecular level 
remain not fully understood, the recent advances 
in autophagy research present a potential target for 
manipulation of autophagy in human diseases 
(Figure 2).
     The following reviews aim at outlining our current 
understanding of mechanisms involved in autophagy 
activation, and its important roles in human phy-
siology and diseases, including diabetes mellitus, 
neurodegenerative disorders, infectious diseases 
and cancer.
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